Cargando…
MVA-brachyury Tricom vaccine/pembrolizumab: Various toxicities: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818683/ http://dx.doi.org/10.1007/s40278-021-89699-7 |
Ejemplares similares
-
Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
por: Heery, Christopher R, et al.
Publicado: (2015) -
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
por: DeMaria, Peter J, et al.
Publicado: (2021) -
Pembrolizumab: Various toxicities: case report
Publicado: (2021) -
Linagliptin/metformin/pembrolizumab interaction: Various toxicities: case report
Publicado: (2022) -
Methylprednisolone/pembrolizumab/prednisolone: Various toxicities and lack of efficacy: case report
Publicado: (2021)